Northwest Biotherapeutics (NWBO) Announced 1-for-16 Reverse Split in Preparation for $25M Offering and Nasdaq Listing

Go back to Northwest Biotherapeutics (NWBO) Announced 1-for-16 Reverse Split in Preparation for $25M Offering and Nasdaq Listing